Skip to main content
Fig. 6 | BMC Medical Genomics

Fig. 6

From: Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation

Fig. 6

Validation of SPAG1 expression and its clinical significance in AML. a SPAG1 expression in 15 controls, 86 AML patients at diagnosis time, and 45 AML patients who achieved complete remission. b ROC curve analysis of SPAG1 expression in distinguishing AML from controls. c SPAG1 expression at diagnosis time in AML patients who did and did not achieve CR after 1–2 course induction therapy. d Kaplan–Meier survival curves of overall survival regarding SPAG1 expression in whole-cohort AML from our hospital

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us